Here, we found that overexpression of antioxidant OXR1 in neurons before onset of symptoms modifies SOD1-mediated ALS and delays inflammatory response, and presented evidence that a novel neuronal antioxidant modulates the cross-talk between neuroinflammation and oxidative stress during neurodegenerative pathogenesis. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.